CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
6.05
-1.06 (-14.91%)
At close: Jun 27, 2025, 4:00 PM
6.11
+0.06 (0.99%)
After-hours: Jun 27, 2025, 6:27 PM EDT
CervoMed Market Cap
CervoMed has a market cap or net worth of $52.65 million as of June 27, 2025. Its market cap has decreased by -69.46% in one year.
Market Cap
52.65M
Enterprise Value
17.41M
1-Year Change
-69.46%
Ranking
Category
Stock Price
$6.05
Market Cap Chart
Since June 29, 2020, CervoMed's market cap has increased from $50.94M to $52.65M, an increase of 3.36%. That is a compound annual growth rate of 0.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 52.65M | 158.55% |
| Dec 31, 2024 | 20.36M | -52.97% |
| Dec 29, 2023 | 43.30M | 319.57% |
| Dec 30, 2022 | 10.32M | -67.34% |
| Dec 31, 2021 | 31.59M | -38.30% |
| Dec 31, 2020 | 51.21M | 0.53% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.92B |
| Johnson & Johnson | 366.76B |
| AbbVie | 329.73B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 275.13B |
| Abbott Laboratories | 232.63B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |